| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Accounting Officer
1 company
Lyon Joseph Douglas is a See Remarks at CORCEPT THERAPEUTICS INC. Recent SEC Form 4 filings include 0 buys and 18 sells.
Estimated insider holdings value: $549K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 5,000 | $79.53 | $397,631.50 | -32.7% | -54.9% | - | |
| Nov 3, 2025 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 5,000 | $73.65 | $368,244.50 | -32.7% | -45.1% | - | |
| Oct 1, 2025 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 5,000 | $84.75 | $423,765.75 | -12.3% | -16.7% | - | |
| Sep 2, 2025 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 5,000 | $70.25 | $351,247.44 | -19.8% | +11.8% | - | |
| Aug 1, 2025 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 5,823 | $67.51 | $393,127.62 | -36.6% | +4.7% | - | |
| Jul 18, 2025 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 4,077 | $73.47 | $299,543.74 | -16.8% | +12.2% | - | |
| Jul 1, 2025 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 100 | $73.51 | $7,350.50 | -1.0% | +21.1% | - | |
| Jun 2, 2025 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 5,000 | $78.04 | $390,218.44 | -21.0% | -0.4% | - | |
| May 1, 2025 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 9,350 | $71.96 | $672,781.12 | -50.9% | -2.2% | - | |
| Apr 1, 2025 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 200,650 | $100.51 | $20,167,953.55 | -71.7% | -20.2% | -54.3% |